MedTrace Logo

Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.

NCT00154960 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2005-11-28

No results posted yet for this study

Summary

In this, here we want to present a new method for analysis variation in gene copy number for patients and carriers of SMA. This is a relative quantitation method and, therefore, relies on the inclusion of one or more internal control or reference sequences; quantitation of DNA is relative to this reference sequence of known copy number. A peak height from within a potentially duplicated or deleted target region is amplified simultaneously with a disomic reference region in a multiplex PCR system.

Conditions

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yi-Ning Su, MD,PhD · National Taiwan University Hospital

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00154960 on ClinicalTrials.gov